Researchers examined unnecessary antibiotic use among adults hospitalized for asthma exacerbation without lung infection.
The FDA did not approve a generic version of the inhaled lung drug Advair for the second time due to "minor deficiencies" in the treatment.
A recent study examined the impact of medications intended to aid quitting on long-term cessation rates in adult smokers.
A Class II recall is active for a prescription vasodilator used to treat pulmonary arterial hypertension in adults.
The FDA has approved an add-on maintenance treatment for patients with severe asthma and an eosinophilic phenotype aged 12 years or older.